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1. Introduction 
Human transcortin (corticosteroid binding glob- 
ulin), that specifically binds glucocorticoid hormones 
in blood plasma, consists of a single polypeptide chain 
and several osidic chains accounting for 27% (w/w) of 
the molecule [11. The polypeptide chain contains two 
cysteine residues and no disulphide bridge [l-3] but 
heat or acid inactivation of transcortin results in an 
aggregation and a disulphide bridge dimer formation 
which occur concomitantly with an important modi- 
fication of the secondary structure [1,4]. 
In-the native conformation, only one of both 
sulphyd~l groups is shown to react with sodium 
p-chloromercuribenzoate (PCMB) [2] or with 5$-d& 
thiobis(2-nitrobenzoic a id) (DTNB) [5]. This is in 
disagreement with our own observation since we were 
not able to detect any thiol group on native trans- 
cortin (free or bound to cortisol) [6]. 
The purpose of the present work is to provide an 
explanation of this apparent discrepancy, which is 
essential to the study of the cortisol binding site. 
Indeed, Khan and Rosner have observed the modifi- 
cation of the accessible cysteine residue by a hormone 
analogue, 6~-bromoprogesterone; since the modifica- 
tion is accompanied by a loss of cortisol binding, 
they have claimed that the accessible cysteine residue 
is present in the binding site [5]. In this paper, it will 
be shown that the accessible cysteine sulphydryl group 
seems to be partially oxidized to sulphenic acid. This 
cysteine residue had the same accessibility in free 
transcortin as in transcortin-cortisol complex; it could 
be modified by ethylene imine without loss of binding 
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activity. Thus it cannot be considered as an essential 
amino acid for cortisol binding even if it is present in 
the binding site as suggested in a recent work ES). 
2. Materials and methods 
Cortisol was obtained from Steraloids and [ 1 ,2-3H3- 
cortisol(30 Cifmmol) from Radiochemical Centre, 
Amersham. DTNB, dithiothreitol (DTT) and ethylene 
imine were purchased from Pierce Chemicals. All 
other used materials were of Analytical Reagent 
grade of purity and all solutions were made with 
deionized and glass distilled water. 
2.1. Cortisol-free transcortin 
Transcortin was obtained by affinity chromatog- 
raphy as an equimolar transcortin-cortisol complex 
[ 1,7]. The freezedried powder was kept at -7O*C 
until use. After solub~~ation, its molar concentra- 
tion was determined from A 280 ,,,,, measurements 
taking a mol. wt 49 500 (E: zdrn’ at 280 nm = 0.70) 
[I]. Cortisol was assayed by fluorimetry [SJ. 
Cortisol-free tr~~ortin was prepared, just before 
use, in the appropriate buffer for chemical modifica- 
tion. For that purpose, a dextran-coated charcoal 
suspension was made of 10 mg/ml charcoal Norit 
(Prolabo) and 1 mg/ml dextran T-70 (Pharmacia) in 
the same buffer as in the transcortin solution. To 
one volume of tr~sco~in~ortisol complex solu- 
tion (24 mgfml) was added 1 vol. suspension. After 
a 30 min incubation at 37”C, the mixture was cen- 
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trifuged at 2000 X g, 10 min and the supernatant 
filtered through Whatman no. 1, if necessary to get 
a clear solution. This method was shown to effi- 
ciently remove most of the cortisol (about 95%) 
from transcortin without denaturation. 
2.2. Sulphydryl group determination 
Titration of free or cortisol bound transcortin with 
DTNB was performed in 0.1 M Tris-HCl buffer, 
pH 8.0, containing 0.001 M disodium EDTA. Trans- 
cortin solution (0.02 mM) with or without denaturant, 
was incubated with 35 ~1 DTNB (4 rn~~) in final 
vol. 1 ml for 15 min and the A4r2 nm was determined 
along with appropriate reagent and sample blanks. 
When 6 M guanidine hydrochloride was included in 
the incubation mixture, a 60 min preincubation at 
5O’C took place before addition of DTNB; when 2% 
sodium dodecyisulfate was used as denaturant, the 
transcortin solution was boiled during 3 min before 
addition of DTNB. A molar extinction coefficient 
of 13 600 M-r cm-’ was assumed to calculate the 
number of sulphydryl groups titrated in absence of 
sodium dodecyl sulphate (SDS) [9]. This coefficient 
was corrected when the reaction was carried out in 
the presence of 2% SDS: the titration was found to 
be linear with cysteine hydrochloride in the usual 
concentrations (0-10Y4 M) but the molar absorption 
coefficient exhibited a lower value, 12 100 M-’ cm-’ 
which agreed with the reported data in the presence 
of detergents (12 500 M-’ cm-‘) [IO]. 
Titration of cortisol-free transcortin with PCMB 
was performed in 0.05 M sodium phosphate buffer, 
pH 7.0 [ 111, with or without 2% SDS. Titration of 
transcortin-cortisol complex was not carried out 
since cortisol has a high molar absorbance (e at 
258 nm = 15 900 M-’ cm-’ [ 121) which interferes 
with the thiol reaction product (E at 250 nm = 
7600 M-* cm-‘) [l 11. 
2.3. Activity assay of transcortin 
The transcortin-cortisol complex solution 
(0.02-0.04 mM) in the buffer used for chemical 
modification was added together with 0.5 &i/ml 
[‘H]cortisol(30 Ci/mmol) and incubated 90 min 
at 37°C to reach equilibrium. When cortisol-free 
transcortin was used, [3H]cortisol (40 Cijmol) was 
added to a final molar concentration slightly higher 
than that of transcortin (0.025-0.050 mM) before 
the activity assay. 
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Binding activities were tested on 0.1 ml aliquots 
at 0°C in duplicate, by the dextran-coated 
charcoal method described in [6]. A systematic 
comparison was made between chemically modi- 
fied transcortin samples, a reference sampie was 
treated in a similar manner but without reagent and 
native transcortin. 
2.4. General methods 
Polyacrylamide gel electrophoreses were per- 
formed with 7.5% acrylamide and Tris-glycine 
buffer, pH 8.3 by the method in [14], 
Metal ions were determined on a 0.02 mM trans- 
cortin solution in 0.05 M sodium phosphate buffer, 
pH 7.4, with an Atomic absorption spectrophotom- 
eter IL 151. 
Amino acid analyses were performed with a 
Jeol 5 AH amino acid analyser. Samples for acid 
hydrolysis were treated at 110°C for 24 h with 
5.6 N HCl in evacuated, sealed tubes. 
3. Results 
3.1.3Wphydrylgroup determination 
The number of sulphydryl groups present in trans- 
cortin was determined under various conditions; the 
results are shown in table 1. No thiol group was 
Table 1 
Titration of the sulphydryl groups of transcortin 
Conditions -SH groups/m01 transcortin 
not reduced reduced with 







a Determination with DTNB 
b Determination with PCMB 
Reduction with DTT was performed in 0.1 M Tris-HC1 
buffer, pH 8, for 1 h in the dark. The solution (1 ml) was 
then desalted through a Bio-gel P-6 column (0.8 X 18 cm) 
equilibrated with the same buffer. The eluted protein peak 
fractions were pooled and concentrated to 1 ml under 
nitrogen at 4°C in an Amicon micro-ultrafiltration appara- 
tus equipped with Diaflo membrane (PM 10 type). Titra- 
tion of sulphydryl groups was carried out as described in 
section 2. Each number represents the average vahre of 
4 determinations with different preparations of transcortin 
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detected on native transcortin (free or bound to cor- 
tisol) but 1 -SH group/m01 was titrable in the pres- 
ence of 2% SDS. Reduction of transcortin with 5 mM 
dithiothreitol under native conditions led to an -SH 
content increase without change of the cortisol bind- 
ing activity: 1 -SH group/m01 was titrable in native 
conditions, 2 groups in the presence of 2% SDS. 
Determination in 6 M guanidine hydrochloride gave 
similar results as in 2% SDS. 
Since transcortin contains 2 cysteine residues/mol, 
we may assume that one is sterically hindered and 
denaturation is necessary for titration of its -SH 
group. The second residue is available under native 
conditions but its -SH group is blocked and can be 
determined only after reduction. 
3.2. Nature of the blocking agent on the available 
sulphydryl group 
A number of different divalent metals were 
assayed. Mercury, iron and zinc were not detectable; 
traces of lead and copper, 0.09 and 0.08 atom/m01 
transcortin were detected, respectively, but these 
quantities are insufficient to explain the blockage 
of 1 -SH group/mol. 
Another possibility explored was a disulphide 
formation in hemolysed blood plasma with a thiol 
peptide (such as glutathione) or with free cysteine. 
For this investigation, 2 X lo-” mol were reduced 
in 1 ml volatile buffer (0.2 M ammonium bicarbo- 
nate buffer, pH 8.0) with 1% 2-mercaptoethanol 
under nitrogen, in the dark during 16 h; the solu- 
tion was then desalted through a Bio-gel P 6 column 
equilibrated with 0.02 M ammonium bicarbonate 
buffer, pH 8.0 and the salt fraction examined with 
an amino acid analyser. No amino acids were 
observed either before or after acid hydrolysis 
although the available -SH group was effectively 
regenerated. 
The presence of both cysteic acid and half-cystine 
residues was detected in unreduced transcortin after 
acid hydrolysis: 0.86 and 0.77 residues/m01 respec- 
tively. The occurrence of cysteic acid in native trans- 
cortin cannot be assumed since that degree of oxida- 
tion cannot be reversed by DTT; the question then 
arises as to the presence of sulphenic (-SOH) or 
sulphinic (-SOzH) acid which can be reduced to 
thiol [ 151. It has been suggested that sulphenic acids, 
unlike disulphides, may be reduced to thiols by 
sodium arsenite, a very mild reductant [ 16,171. The 
effects of arsenite and of another mild reductant, 
sodium ascorbate, were therefore studied. It was 
found that arsenite or ascorbate regenerated the 
available -SH group, like DTT (table 2). 
3.3. Saminoethylation of the available sulphydryl 
group 
Direct evidence by amino acid analysis of S-amino- 
ethylcysteine could not be obtained. Indeed, S-amino- 
ethylcysteine was eluted in amino acid chromatograms 
in a narrow space between lysine and histidine which 
are present in transcortin acid hydrolysate with, 
respectively, a 15fold and a 9-fold molar excess. 
However, indirect evidence for -SH modification 
was given by titration of sulphydryl groups before 
and after aminoethylation. 
Although 2 -SH groups/mol were determined in 
2% SDS solution of reduced transcortin, a single -SH 
group was detected after aminoethylation in native 
conditions. Results were essentially the same for 
Table 2 
Effect of reductants and aminoethylation in native 
conditions on sulphydryl content of transcortin 
Reductants -SH groups/m01 transcortin 
(determination in 2% SDS) 
None 
0.01 M dithiothreitol 
0.20 M arsenite 
0.20 M ascorbate 







Saminoethylation was performed in native conditions with 
ethylene imine [ 131. Free transcortin solution, 0.04 mM 
in 1 M Tris-HCl buffer, pH 8.5 containing 0.001 M disodium 
EDTA, was reduced with 10 mM DTT in the dark over 1 h; 
it was then divided into three 1 ml portions. a The first was 
mixed with ethylene imine during 2 h (6 additions of 10 ~1 
at 10 mm intervals over 1 h. b To the second portion, [ ‘H]cor- 
tisol(40 Ci/mol) was added to final cont. 0.05 mM before 
reaction with ethylene imine. ’ The third portion was 
untreated. Reduction by arsenite and ascorbate was carried 
out in 0.1 M Tris-HCl buffer, pH 8.1, containing 0.001 M 
disodium EDTA for 60 min in the dark at 30°C. (1.1 ml 
aliquots of all reaction mixtures were removed for testing 
the binding activity and the remaining solutions were 
desalted and titrated as in table 1 
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unbound and cortisol bound transcortin (table 2). 
AS no -SH group was detectable in the absence of 
SDS, the remaining thiol group after aminoethylation 
corresponds to the buried cysteine residue which was 
not available to ethylene imine during the reaction. 
S-aminoethylation of transcortin in native conditions 
thus permitted selective modification of the accessible 
cysteine residue. This modification induced no loss 
of binding activity. 
4. Discussion 
The experimental evidence presented here strongly 
indicates that the available sulphydryl group of trans- 
cortin is converted to a stabilized sulphenic acid. 
Fries acid (anthraquinone-1 -sulphenic acid) [ 181 and 
two other closely related compounds [ 19,201 are the 
only successfully isolated sulphenic acids. It has been 
proposed that the stability of these particular sulphenic 
acidsis probably due to hydrogen bonding or to other 
strong interactions of the oxidized sulfur with the 
aromatic 9 JO quinone system [20]. Aliphatic sulphenic 
acids lack this stabilization and therefore cannot be 
isolated. The stability of the sulphenic derivative in 
transcortin can be attributed to its steric and chemical 
environment. 
The presence of cysteine sulphenic acid has been 
described in glyceraldehyde 3-phosphate dehydro- 
genases and its oxidation is suggested to occur during 
the isolation procedure [ 161. The occurrence of 
stabilized sulphenic acid is also suggested in papain 
[ 171. Oxidation of the accessible cysteine residue of 
transcortin that we isolated may occur during collec- 
tion of biological samples of serum. Indeed, the pool 
of serum which was often hemolysed was usually 
kept at room temperature over 2 days and at 4°C 
over 1 week for collection before freezing at -20°C. 
The question arises as to the role of this accessible 
cysteine residue in cortisol binding affinity of trans- 
cortin. Three amino acids have been identified in 
different regions of the site by affinity labelling: we 
have suggested the presence of an histidine residue 
and of a methionine residue [6], a third amino acid 
is the accessible cysteine residue which is suggested 
to be present in the vicinity of the carbonatom 6 of 
cortisol by Khan and Rosner [5]. However, this 
residue was shown here to be non-essential for cor- 
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tisol binding. Khan and Rosner also showed that 
PCMB does not inactivate transcortin. Recently 
Stroupe et al. [21] have observed that the degree of 
ionization of cysteine residue is unlikely to affect 
the dissociation rate constant of transcortin-steroid 
complexes in contrast to histidyl and arginyl residues. 
All these observations strongly suggest hat the 
accessible cysteine residue of transcartin may be 
present at the binding site between the cortisol 
crevice and the outside of the molecule so as to be 
available from both faces. 
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